Human Papillomavirus (HPV) Infection in Pregnancy

The purpose of this study is to determine if maternal infection with human papillomavirus (HPV) is associated with pregnancy complications including spontaneous preterm delivery (sPTD), severe preeclampsia (PE), and poor fetal growth.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Papillomavirus Infections Communicable Diseases DNA Virus Infections Disease Attributes Female Urogenital Diseases and Pregnancy Complications Genital Diseases Infections Pathologic Processes Pathological Conditions, Signs and Symptoms Pregnancy Complications Sexually Transmitted Diseases Sexually Transmitted Diseases, Viral Tumor Virus Infections Urogenital Diseases Virus Diseases

Age range

13 year–45 year

Sex eligibility

Female

Study type

Observational

Primary location

Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All women presenting for prenatal care at the Hospital of the University of Pennsylvania or affiliated clinics

Exclusion criteria

Multiple gestations
Medical conditions such as diabetes, chronic hypertension, renal disease
Fetal malformations or chromosomal anomalies
Fetal death

Sponsors and collaborators

Lead sponsor

University of Pennsylvania

Other

Collaborators

National Institutes of Health (NIH)

Registry information

Important dates

Study start: 2005
Primary completion: 2007
Study completion: 2007
First posted: Sep 19, 2005
Registry last updated: Aug 17, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed